RhoB determines tumor aggressiveness in a murine EGFRL858R-induced adenocarcinoma model and is a potential prognostic biomarker for lepidic lung cancer

Clinical Cancer Research

Volumn 20, Issue 24, 2014, Pages 6541-6550

  Calvayrac, Olivier ^a,b,c   Pradines, Anne ^a,b,c   Raymond Letron, Isabelle ^b   Rouquette, Isabelle ^b,d   Bousquet, Emilie ^a,b,c   Lauwers Cances, Valérie ^e   Filleron, Thomas ^c   Cadranel, Jacques ^f   Beau Faller, Michèle ^g   Casanova, Anne ^a,b,c   Milia, Julie ^b,h   Favre, Gilles ^a,b,c   Mazières, Julien ^a,b,h  

^a CANCER RESEARCH CENTER OF TOULOUSE   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c INSTITUT CLAUDIUS REGAUD   (France)

^d CHU RANGUEIL   (France)

^e TOULOUSE UNIVERSITY HOSPITAL   (France)

^f HÔPITAL TENON   (France)

^g HÔPITAL DE HAUTEPIERRE   (France)

^h SERVICE DE PNEUMOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOB PROTEIN; UNCLASSIFIED DRUG; RHOB GUANINE NUCLEOTIDE BINDING PROTEIN; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER INFILTRATION; CANCER MODEL; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; KNOCKOUT MOUSE; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUSE; MULTIVARIATE ANALYSIS; NON SMALL CELL LUNG CANCER; NONHUMAN; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; TUMOR INVASION; ADENOCARCINOMA; ADULT; AGED; ANIMAL; CELL TRANSFORMATION; DISEASE COURSE; DISEASE MODEL; GENE EXPRESSION; GENETICS; LUNG TUMOR; MIDDLE AGED; MORTALITY; MUTATION; PATHOLOGY; PROGNOSIS; RISK FACTOR; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MIDDLE AGED; MUTATION; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RHOB GTP-BINDING PROTEIN; RISK FACTORS; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84919772066     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-14-0506     Document Type: Article

References (45)

1. Ferlay J, Shin HR, Bray F, Forman D., Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN2008. Int J Cancer 2010;127:2893-917.
2. Goldstraw P, Ball D, Jett J., Le Chevalier T, Lim E, Nicholson A., et al. Non-small cell lung cancer. Lancet 2011;378:1727-40.
3. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100: 57-70.
4. Kratz JR, He J, Van Den Eeden SK, Zhu ZH, Gao W, Pham PT, et al. A practical molecular assay to predict survival in resected non-squamous, non-small cell lung cancer: development and international validation studies. Lancet 2012;379:823-32.
5. Vannini I, Fanini F, Fabbri M. microRNAs as lung cancer biomarkers and key players in lung carcinogenesis. Clin Biochem 2013;46: 918-25.
6. Mazieres J, Antonia T, Daste G., Muro-Cacho C, Berchery D, Tillement V., et al. Loss of RhoB expression in human lung cancer progression. Clin Cancer Res 2004;10:2742-50.
7. Sato N, Fukui T, Taniguchi T., Yokoyama T, Kondo M, Nagasaka T., et al. RhoB is frequently downregulated in non-small cell lung cancer and resides in the 2p24 homozygous deletion region of a lung cancer cell line. Int J Cancer 2007;120:543-51.
8. Huang M, Prendergast GC. RhoB in cancer suppression. Histol Histopathol 2006;21:213-8.
9. Karlsson R, Pedersen ED, Wang Z, Brakebusch C. Rho GTPase function in tumorigenesis. Biochim Biophys Acta 2009;1796:91-8.
10. Ridley AJ. RhoA, RhoB and RhoC have different roles in cancer cell migration. J Microsc 2013;251:242-9.
11. Chen Z, Sun J, Pradines A., Favre G, Adnane J, Sebti SM. Both farnesylated and geranylgeranylated RhoB inhibit malignant transformation, induce apoptosis and suppress human tumor growth in nude mice. J Biol Chem 2000;275:17974-8.
12. Mazieres J, Tillement V, Allal C., Clanet C, Bobin L, Chen Z., et al. Geranylgeranylated, but not farnesylated, RhoB suppresses Ras transformation of NIH-3T3 cells. Exp Cell Res 2005;304:354-64.
13. Jiang K, Delarue FL, Sebti SM. EGFR, ErbB2 and Ras but not Src suppress RhoB expression while ectopic expression of RhoB antagonizes oncogene-mediated transformation. Oncogene 2004;23: 1136-45.
14. Liu AX, Rane N, Liu J.P., Prendergast GC. RhoB is dispensable for mouse development, but it modifies susceptibility to tumor formation as well as cell adhesion and growth factor signaling in transformed cells. Mol Cell Biol 2001;21:6906-12.
15. Forget MA, Desrosiers RR, Del M, Moumdjian R., Shedid D, Berthelet F, et al. The expression of rho proteins decreases with human brain tumor progression: potential tumor markers. Clin Exp Metastasis 2002;19: 9-15.
16. Adnane J, Muro-Cacho C, Mathews L., Sebti SM, Munoz-Antonia T. Suppression of rho B expression in invasive carcinoma from head and neck cancer patients. Clin Cancer Res 2002;8:2225-32.
17. Couderc B, Pradines A, Rafii A., Golzio M, Deviers A, Allal C., et al. In vivo restoration of RhoB expression leads to ovarian tumor regression. Cancer Gene Ther 2008;15:456-64.
18. Bousquet E, Mazieres J, Privat M., Rizzati V, Casanova A, Ledoux A., et al. Loss of RhoB expression promotes migration and invasion of human bronchial cells via activation of AKT1. Cancer Res 2009;69: 6092-9.
19. Wislez M, Beer DG, Wistuba I, Cadranel J., Saijo N, Johnson BE. Molecular biology, genomics, and proteomics in bronchioloalveolar carcinoma. J Thorac Oncol 2006;1:S8-12.
20. Politi K, Zakowski MF, Fan P.D., Schonfeld EA, Pao W, Varmus HE. Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors. Genes Dev 2006;20: 1496-510.
21. Rouquette I, Lauwers-Cances V, Allera C., Brouchet L, Milia J, Nicaise Y., et al. Characteristics of lung cancer in women: importance of hormonal and growth factors. Lung Cancer 2012;76:280-5.
22. Cadranel J, Quoix E, Baudrin L., Mourlanette P, Moro-Sibilot D, Morere JF, et al. IFCT-0401 trial: a phase II study of gefitinib administered as first-line treatment in advanced adenocarcinoma with bronchioloalveolar carcinoma subtype. J Thorac Oncol 2009;4:1126-35.
23. Travis WD, Brambilla E, Noguchi M., Nicholson AG, Geisinger KR, Yatabe Y, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011;6:244-85.
24. Goldstraw P, Crowley J, Chansky K., Giroux DJ, Groome PA, RamiPorta R, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007;2:706-14.
25. Groome PA, Bolejack V, Crowley J.J., Kennedy C., Krasnik M, Sobin LH, et al. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007;2:694-705.
26. Nikitin AY, Alcaraz A, Anver M.R., Bronson RT, Cardiff RD, Dixon D, et al. Classification of proliferative pulmonary lesions of the mouse: recommendations of the mouse models of human cancers consortium. Cancer Res 2004;64:2307-16.
27. Lajoie-Mazenc I., Tovar D, Penary M., Lortal B, Allart S, Favard C., et al. MAP1A light chain-2 interacts with GTP-RhoB to control epidermal growth factor (EGF)-dependent EGF receptor signaling. J Biol Chem 2008;283:4155-64.
28. Garfield DH, Cadranel J, West HL. Bronchioloalveolar carcinoma: the case for two diseases. Clin Lung Cancer 2008;9:24-9.
29. Gerald D, Adini I, Shechter S., Perruzzi C, Varnau J, Hopkins B., et al. RhoB controls coordination of adult angiogenesis and lymphangiogenesis following injury by regulating VEZF1-mediated transcription. Nat Commun 2013;4:2824.
30. Zalcman G, Closson V, Linarescruz G., Lerebours F, Honore N, Tavitian A., et al. Regulation of ras-related RhoB protein expression during the cell cycle. Oncogene 1995;10:1935-45.
31. Fritz G, Kaina B, Aktories K. The ras-related small GTP-binding protein RhoB is immediate-early inducible by DNA damaging treatments. J Biol Chem 1995;270:25172-7.
32. Liu A, Cerniglia GJ, Bernhard E.J., Prendergast GC. RhoB is required to mediate apoptosis in neoplastically transformed cells after DNA damage. Proc Natl Acad Sci U S A 2001;98:6192-7.
33. Luis-Ravelo D., Anton I, Zandueta C., Valencia K, Pajares MJ, Agorreta J, et al. RHOB influences lung adenocarcinoma metastasis and resistance in a host-sensitive manner. Mol Oncol 2014;8: 196-206.
34. Fero ML, Randel E, Gurley K.E., Roberts JM, Kemp CJ. The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature 1998; 396:177-80.
35. Kwabi-Addo B., Giri D, Schmidt K., Podsypanina K, Parsons R, Greenberg N., et al. Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression. Proc Natl Acad Sci U S A 2001;98:11563-8.
36. Meyer N, Peyret-Lacombe A, Canguilhem B., Medale-Giamarchi C, Mamouni K, Cristini A., et al. RhoB promotes cancer initiation by protecting keratinocytes from UVB-induced apoptosis but limits tumor aggressiveness. J Invest Dermatol 2014;134:203-12.
37. Maeda Y, Tsuchiya T, Hao H., Tompkins DH, Xu Y, Mucenski ML, et al. Kras(G12D) and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung. J Clin Invest 2012;122:4388-400.
38. Kerr KM, MacKenzie SJ, Ramasami S, Murray G.I., Fyfe N., Chapman AD, et al. Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in atypical adenomatous hyperplasia and pulmonary adenocarcinoma. J Pathol 2004;203:638-44.
39. Awaya H, Takeshima Y, Amatya V.J., Ishida H., Yamasaki M, Kohno N, et al. Loss of expression of E-cadherin and beta-catenin is associated with progression of pulmonary adenocarcinoma. Pathol Int 2005; 55:14-8.
40. Borczuk AC. Assessment of invasion in lung adenocarcinoma classification, including adenocarcinoma in situ and minimally invasive adenocarcinoma. Mod Pathol 2012;25:S1-10.
41. Garfield DH, Cadranel JL, Wislez M, Franklin W.A., Hirsch FR. The bronchioloalveolar carcinoma and peripheral adenocarcinoma spectrum of diseases. J Thorac Oncol 2006;1:344-59.
42. Henderson DJ, Ybot-Gonzalez P, Copp AJ. RhoB is expressed in migrating neural crest and endocardial cushions of the developing mouse embryo. Mech Dev 2000;95:211-4.
43. Vignal E, de Santa Barbara P, Guemar L, Donnay JM, Fort P, Faure S. Expression of RhoB in the developing Xenopus laevis embryo. Gene Expr Patterns 2007;7:282-8.
44. Wheeler AP, Ridley AJ. RhoB affects macrophage adhesion, integrin expression and migration. Exp Cell Res 2007;313:3505-16.
45. Vega FM, Colomba A, Reymond N., Thomas M, Ridley AJ. RhoB regulates cell migration through altered focal adhesion dynamics. Open Biol 2012;2:120076.